MITA names Dennis Durmis chair of its Board of Directors

The Medical Imaging & Technology Alliance (MITA) announced today that Dennis Durmis, senior vice president of Bayer Radiology, Americas region, will be the next chair of its Board of Directors.

Dennis Durmis, MITA
Dennis Durmis. Photo courtesy of MITA.

“It is an honor to serve as the next chair of MITA Board of Directors,” said Durmis, in a prepared statement. “The medical imaging landscape is rapidly changing, and MITA and its Members are at the forefront of advancing the latest innovations and technological developments. I look forward to leading MITA during this exciting time.”

Durmis has been with Bayer for the past 19 years. Prior to assuming his current position, he led Bayer’s global MEDRAD Service business and led all aspects of MEDRAD Emerging Markets growth initiative.

“Denny has been an important leader and an invaluable member of the MITA board,” said Patrick Hope, executive director of MITA, in the same statement. “We look forward to his leadership as chair to guide MITA during this very important time in the medical imaging industry.”

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.